IFAH-Europe Welcomes G7 Summit’s Report Urging One Health Approach to AMR and Call to Incentivise R&D

Written by IFAH-Europe on 27 May 2016 in Press Release
Press Release

Brussels, 27 May 2016 – At the close of the Summit in Ise-Shima (Japan), G7 leaders issued a declaration outlining their current thinking on antimicrobial resistance. In advance of this Summit meeting, IFAH-Europe had called on the G7 Summit leaders to consider a holistic One Health approach in dealing with antimicrobial resistance (AMR) and infectious diseases, as a reminder to policy-makers that AMR is not only a topic of concern for human and public health, but also for animal health.

Brussels, 27 May 2016 – At the close of the Summit in Ise-Shima (Japan), G7 leaders issued a declaration outlining their current thinking on antimicrobial resistance. In advance of this Summit meeting, IFAH-Europe had called on the G7 Summit leaders to consider a holistic One Health approach in dealing with antimicrobial resistance (AMR) and infectious diseases, as a reminder to policy-makers that AMR is not only a topic of concern for human and public health, but also for animal health.

“We are very happy to see that the G7 leaders have included in their report the importance of working together between sectors (human and animal health, agriculture, food and the environment) in order to improve access to and preserve antibiotics’ effectiveness for future use,” commented Roxane Feller,

Secretary-General of IFAH-Europe. “We welcome the G7 leaders’ recommendations for an acceleration in our efforts to tackle resistance through improved inter-sectoral surveillance, for example. We are also encouraged that they recognise the need for the development of new diagnostics and increased innovation in the human and animal health sectors to combat infectious diseases in light of AMR. The call for incentives to fight AMR and promote R&D and innovation is very much welcomed by our industry and we look forward to the next steps in regards to the implementation of the WHO’s Global Action Plan at the UN General Assembly’s meeting on AMR in September 2016, but also to the meeting of Europe’s Agriculture and Health ministers to discuss the EU’s strategy to tackle AMR next month1.”

“Europe’s animal health industry is committed to continue playing its part in the fight against AMR, as part of this inter-sector collaboration One Health approach in order to preserve the use of antibiotics for the generations to come to safeguard animal health and welfare, as well public health, food safety and food security.”

About the author

IFAH-Europe is the representative body of manufacturers of veterinary medicines, vaccines and other animal health products in Europe. It represents innovators and generics alike, as well as large, medium-sized and small companies. IFAH-Europe promotes a single market in veterinary medicines across the EU ensuring the availability of medicines to protect the health and welfare of animals.
Follow IFAH-Europe on @IFAHEurope
Like us on Facebook: www.facebook.com/WeCare.petsEurope
 
For further information, please contact
Kim Hardie - Communications Director
Tel: +32 2 543 75 75
E-mail k.hardie@ifahsec.org

Share this page

Tags

Categories

Partner content

This content is published by the Parliament Magazine on behalf of our partners.

Related Partner Content

PM+: Veterinary medicines review must put investment in innovation first
19 May 2015

Current EU veterinary medicines review lacks focus on ROI for innovative companies, argues IFAH-Europe's Rick Clayton.

PM+: EU must close illegal fishing loopholes for vessels operating outside European waters
20 October 2015

MEPs must help end the current lack of transparency, accountability and sustainability in EU external fisheries rules, argues Lasse Gustavsson.

GMOs: Time to stand up for EU law and innovation
2 June 2016

MEPs have the chance to support innovation and evidence-based authorisation procedures when they meet next week in Strasbourg, says Pedro Narro Sanchez.